These results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a singular approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-related disorders. Based upon offered science the https://nicolauss592cby3.ageeksblog.com/profile